Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma
Bradley A. McGregor, Aly‐Khan A. Lalani, Wanling Xie, John A. Steinharter, Ziad Bakouny, Dylan J. Martini, Justin H. Fleischer, Sarah Abou-Alaiwi, Amin H. Nassar, Pier Vitale Nuzzo, Marina D. Kaymakcalan, David A. Braun, Xiao X. Wei, Lauren C. Harshman, Mehmet Asım Bilen, Toni K. Choueiri
Topics & Concepts
CabozantinibMedicineOncologyInternal medicineRenal cell carcinomaImmune checkpointClear cell renal cell carcinomaConfidence intervalBlockadeCancerImmunotherapyReceptorRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsFerroptosis and cancer prognosis